Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 First in Human Study Evaluating Safety, Pharmacokinetics and Efficacy of ABBV-400 as Monotherapy and in Combination With Bevacizumab in Adult Subjects With Advanced Solid Tumors

NCT05029882 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT05029882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05029882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 First in Human Study Evaluating Safety, Pharmacokinetics and Efficacy of ABBV-400 as Monotherapy and in Combination With Bevacizumab in Adult Subjects With Advanced Solid Tumors
Lead sponsor
AbbVie
Phase
Phase 1
Overall status
Active, not recruiting
Start date
October 13, 2021
Completion date
November 30, 2027
Enrollment
520 (actual)
Sites
82

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors, colorectal cancer, gastroesophageal adenocarcinoma, non-small cell lung cancer